BMS-986020 sodium structure
|
Common Name | BMS-986020 sodium | ||
---|---|---|---|---|
CAS Number | 1380650-53-2 | Molecular Weight | 504.51 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C29H25N2NaO5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of BMS-986020 sodiumBMS-986020 sodium is a high-affinity lysophosphatidic acid receptor 1 (LPA1) antagonist[1].BMS-986020 sodium inhibits bile acid and phospholipid transporters with IC50s of 4.8 µM, 6.2 µM, and 7.5 µM for BSEP, MRP4, and MDR3, respectively[2]. BMS-986020 sodium is used for the treatment of idiopathic pulmonary fibrosis (IPF)[3]. |
Name | BMS-986020 sodium |
---|
Description | BMS-986020 sodium is a high-affinity lysophosphatidic acid receptor 1 (LPA1) antagonist[1].BMS-986020 sodium inhibits bile acid and phospholipid transporters with IC50s of 4.8 µM, 6.2 µM, and 7.5 µM for BSEP, MRP4, and MDR3, respectively[2]. BMS-986020 sodium is used for the treatment of idiopathic pulmonary fibrosis (IPF)[3]. |
---|---|
Related Catalog | |
Target |
IC50: 4.8 µM (BSEP); 6.2 µM (MRP4); 7.5 µM (MDR3)[2] |
References |
Molecular Formula | C29H25N2NaO5 |
---|---|
Molecular Weight | 504.51 |